Stock Analysis on Net

AmerisourceBergen Corp. (NYSE:ABC)

This company has been moved to the archive! The financial data has not been updated since August 2, 2023.

Enterprise Value to FCFF (EV/FCFF) 

Microsoft Excel

Free Cash Flow to The Firm (FCFF)

AmerisourceBergen Corp., FCFF calculation

US$ in thousands

Microsoft Excel
12 months ended: Sep 30, 2022 Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017
Net income (loss) attributable to AmerisourceBergen Corporation 1,698,820 1,539,932 (3,408,716) 855,365 1,658,405 364,484
Net (income) loss attributable to noncontrolling interests (32,280) 4,676 9,158 (1,230) (42,513)
Net noncash charges 1,176,210 754,656 (662,430) 1,120,690 (2,415) 672,502
Changes in operating assets and liabilities, excluding the effects of acquisitions and divestitures (139,662) 367,322 6,269,028 369,198 (202,089) 467,152
Net cash provided by operating activities 2,703,088 2,666,586 2,207,040 2,344,023 1,411,388 1,504,138
Interest paid, net of tax1 167,707 118,776 96,749 147,814 122,386 49,744
Capital expenditures (496,318) (438,217) (369,677) (310,222) (336,411) (466,397)
Proceeds from sale of property and equipment 6,302 14,439 36,364 1,295 8,100
Free cash flow to the firm (FCFF) 2,380,779 2,361,584 1,970,476 2,182,910 1,205,463 1,087,485

Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).

Item Description The company
FCFF Free cash flow to the firm is the cash flow available to the AmerisourceBergen Corp. suppliers of capital after all operating expenses have been paid and necessary investments in working and fixed capital have been made. AmerisourceBergen Corp. FCFF increased from 2020 to 2021 and from 2021 to 2022.

Interest Paid, Net of Tax

AmerisourceBergen Corp., interest paid, net of tax calculation

US$ in thousands

Microsoft Excel
12 months ended: Sep 30, 2022 Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017
Effective Income Tax Rate (EITR)
EITR1 23.70% 30.50% 35.80% 11.70% 24.50% 60.30%
Interest Paid, Net of Tax
Interest paid, before tax 219,800 170,900 150,700 167,400 162,100 125,300
Less: Interest paid, tax2 52,093 52,125 53,951 19,586 39,715 75,556
Interest paid, net of tax 167,707 118,776 96,749 147,814 122,386 49,744

Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).

1 See details »

2 2022 Calculation
Interest paid, tax = Interest paid × EITR
= 219,800 × 23.70% = 52,093


Enterprise Value to FCFF Ratio, Current

AmerisourceBergen Corp., current EV/FCFF calculation, comparison to benchmarks

Microsoft Excel
Selected Financial Data (US$ in thousands)
Enterprise value (EV) 41,299,807
Free cash flow to the firm (FCFF) 2,380,779
Valuation Ratio
EV/FCFF 17.35
Benchmarks
EV/FCFF, Competitors1
Abbott Laboratories 36.56
Cigna Group 8.60
CVS Health Corp. 8.70
Elevance Health Inc. 9.74
Humana Inc. 5.89
Intuitive Surgical Inc. 242.34
Medtronic PLC 20.77
UnitedHealth Group Inc. 17.62
EV/FCFF, Sector
Health Care Equipment & Services 16.95
EV/FCFF, Industry
Health Care 18.65

Based on: 10-K (reporting date: 2022-09-30).

1 Click competitor name to see calculations.

If the company EV/FCFF is lower then the EV/FCFF of benchmark then company is relatively undervalued.
Otherwise, if the company EV/FCFF is higher then the EV/FCFF of benchmark then company is relatively overvalued.


Enterprise Value to FCFF Ratio, Historical

AmerisourceBergen Corp., historical EV/FCFF calculation, comparison to benchmarks

Microsoft Excel
Sep 30, 2022 Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017
Selected Financial Data (US$ in thousands)
Enterprise value (EV)1 36,473,156 30,235,610 20,514,111 18,995,014 20,769,340 18,335,740
Free cash flow to the firm (FCFF)2 2,380,779 2,361,584 1,970,476 2,182,910 1,205,463 1,087,485
Valuation Ratio
EV/FCFF3 15.32 12.80 10.41 8.70 17.23 16.86
Benchmarks
EV/FCFF, Competitors4
Abbott Laboratories 23.24 23.47 36.94 33.05
Cigna Group 13.38 14.17 9.16 10.24
CVS Health Corp. 10.00 10.30 9.42 12.30
Elevance Health Inc. 13.32 12.74 6.04 12.73
Humana Inc. 14.88 42.03 7.92 8.46
Intuitive Surgical Inc. 85.45 56.01 76.70 54.58
Medtronic PLC 20.32 33.84 21.43 22.07
UnitedHealth Group Inc. 19.30 22.21 15.82 17.51
EV/FCFF, Sector
Health Care Equipment & Services 17.28 19.60 14.85 16.66
EV/FCFF, Industry
Health Care 17.73 17.16 17.81 18.15

Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).

1 See details »

2 See details »

3 2022 Calculation
EV/FCFF = EV ÷ FCFF
= 36,473,156 ÷ 2,380,779 = 15.32

4 Click competitor name to see calculations.

Valuation ratio Description The company
EV/FCFF Enterprise value to free cash flow to the firm is whole company valuation indicator. AmerisourceBergen Corp. EV/FCFF ratio increased from 2020 to 2021 and from 2021 to 2022.